Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ajaypaul, Sukhi"'
Publikováno v:
Expert Opinion on Pharmacotherapy. 21:1851-1865
Achieving reperfusion immediately after acute myocardial infarction improves outcomes; despite this, patients remain at a high risk for mortality and morbidity at least for the first year after the event. Ischemia-reperfusion injury (IRI) has a compl
Publikováno v:
Expert Opinion on Investigational Drugs. 29:33-47
Introduction: Despite current guideline-based, secondary prevention strategies in patients with the acute coronary syndrome, the residual ischemic risk is still at an unacceptable rate, and there is a concomitant high bleeding event rate. These obser
Autor:
Rahul Chaudhary, Kevin P. Bliden, Rohit Chaudhary, Ajaypaul Sukhi, Udaya S. Tantry, Paul A. Gurbel, Marija Kinderytė
Publikováno v:
Cardiovascular Revascularization Medicine. 20:1001-1006
Introduction Low high-density lipoprotein (HDL-C) and inflammation are risk factors for coronary artery disease (CAD). However, limited data are available determining the role of HDL-C sub-particles HDL2-C and HDL3-C for assessing CAD severity in pat
Autor:
Amit Rout, Udaya S. Tantry, Paul A. Gurbel, Rahul Chaudhary, Ajaypaul Sukhi, Ankit Vyas, Rohit Chaudhary, Manila Jindal, Kevin P. Bliden
Publikováno v:
Journal of Thrombosis and Thrombolysis. 48:373-381
Women more often present with angina and non-obstructive coronary artery disease (ANOCA) and have poorer clinical outcomes than men. These findings may be related to sex associated differences in inflammation and thrombogenicity. Consecutive patients
Publikováno v:
Journal of cardiac failure. 28(4)
Background Few data are available on the use of internal jugular vein (IJV) ultrasound parameters to assess central venous pressure and clinical outcomes among patients with suspected or confirmed heart failure (HF). Methods We performed electronic s
Autor:
Udaya S. Tantry, Amit Rout, Mark Gonze, Paul A. Gurbel, Charles C. Cummings, Ajaypaul Sukhi, Kristian Ulloa, Richard Bafford, Peter Mackrell
Publikováno v:
Future cardiology. 16(2)
COMPASS study demonstrated efficacy of dual pathway inhibition with 2.5 mg twice daily rivaroxaban and aspirin in patients with polyvascular disease (coronary artery disease, peripheral arterial disease or both), the underlying mechanism of which is
Autor:
Jalaj Garg, Rahul Chaudhary, Dhanunjaya Lakkireddy, Paul A. Gurbel, Ajaypaul Sukhi, Tushar Sharma, Kevin P. Bliden, Udaya S. Tantry, Mohit K. Turagam
Publikováno v:
Journal of thrombosis and thrombolysis. 49(2)
New guideline recommendations prefer direct oral anticoagulants (DOACs) over warfarin in DOAC-eligible patients with atrial fibrillation and patients with venous thromboembolism. As expected with all antithrombotic agents, there is an associated incr
Autor:
Rahul, Chaudhary, Marija, Kinderytė, Rohit, Chaudhary, Ajaypaul, Sukhi, Kevin, Bliden, Udaya, Tantry, Paul, Gurbel
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions. 20(11)
Low high-density lipoprotein (HDL-C) and inflammation are risk factors for coronary artery disease (CAD). However, limited data are available determining the role of HDL-C sub-particles HDLBlood samples were obtained prior to cardiac catheterization